Institute for Molecular Medicine Finland:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Institute for Molecular Medicine Finland - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9409
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Institute for Molecular Medicine Finland (FIMM) is a research institute that conducts research activities in the fields of human genomics and personalized medicine. The institute develops diagnostics, treatment and prevention of common health problems using Finnish clinical and epidemiological study materials. It offers services such as cell line authentication, capillary sequencing, SNP genotyping and CNV analysis, gene expression analysis, assay development and screening format adaptation, secondary assay testing and microarray printing, among others. FIMM’s technology centre offers bioinformatics, digital microscopy and molecular pathology, extracellular vesicles, genotyping, high content imaging and analysis, high throughput biomedicine (htb), IT, metabolomics, sequencing and single cell analytics, among others. The institute provides doctoral training, FIMMPOD Postdoctoral program and other activities. FIMM is headquartered in Helsinki, Finland.

Institute for Molecular Medicine Finland – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
UPM Biochemicals Partners with Institute for Molecular Medicine Finland 10
Labcyte And Institute For Molecular Medicine Finland Partner To Advance Personalized Medicine In Cancer Treatments 11
Labcyte Extends Agreement with Institute for Molecular Medicine Finland 12
Institute for Molecular Medicine Finland – Key Competitors 13
Institute for Molecular Medicine Finland – Key Employees 14
Institute for Molecular Medicine Finland – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Nov 15, 2017: New Study Suggests a Role for Gene Regulation in Schizophrenia 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Key Facts 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Molecular Medicine Finland, Deals By Therapy Area, 2012 to YTD 2018 8
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UPM Biochemicals Partners with Institute for Molecular Medicine Finland 10
Labcyte And Institute For Molecular Medicine Finland Partner To Advance Personalized Medicine In Cancer Treatments 11
Labcyte Extends Agreement with Institute for Molecular Medicine Finland 12
Institute for Molecular Medicine Finland, Key Competitors 13
Institute for Molecular Medicine Finland, Key Employees 14

List of Figures
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Institute for Molecular Medicine Finland, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Institute for Molecular Medicine Finland:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Otonomy Inc (OTIC):企業の財務・戦略的SWOT分析
    Otonomy Inc (OTIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • TaiDoc Technology Corporation (4736):企業の財務・戦略的SWOT分析
    TaiDoc Technology Corporation (4736) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SuperSonic Imagine SA (SSI):企業の財務・戦略的SWOT分析
    Summary SuperSonic Imagine SA (SuperSonic) operates as a medical device company that develops and supplies ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company offers an ultrasound system, Aixplorer that finds clinical applications in breast, abdomen, liver …
  • E-CO Energi Holding AS-エネルギー分野:企業M&A・提携分析
    Summary E-CO Energi Holding AS (E-CO Energi) owned by the City of Oslo is an energy company. It owns, operates and develops hydroelectric plants. The company is the second largest hydropower producer in Norway. E-CO Energi also carries out the business development in energy and related fields. The c …
  • Tan Viet Securities Joint Stock Company:企業の戦略的SWOT分析
    Tan Viet Securities Joint Stock Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Recro Pharma Inc (REPH):企業の財務・戦略的SWOT分析
    Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Travelodge Hotels Ltd.:企業の戦略・SWOT・財務情報
    Travelodge Hotels Ltd. - Strategy, SWOT and Corporate Finance Report Summary Travelodge Hotels Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Tokyo Electric Power Company Holdings Incorporated (9501)-エネルギー分野:企業M&A・提携分析
    Summary Tokyo Electric Power Company Holdings, Incorporated (TEPCO), formerly Tokyo Electric Power Company, Incorporated, is an integrated energy company. The company generates, transmits, distributes and sells electricity through its subsidiaries. It generates power from various sources such as the …
  • Applied DNA Sciences Inc (APDN):医療機器:M&Aディール及び事業提携情報
    Summary Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company’s products comprise DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DNA se …
  • Boone Electric Cooperative:発電所・企業SWOT分析
    Boone Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hirose Electric Co Ltd (6806):企業の財務・戦略的SWOT分析
    Hirose Electric Co Ltd (6806) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Banco Pan SA (BPAN4):企業の財務・戦略的SWOT分析
    Banco Pan SA (BPAN4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Teradata Corp (TDC):企業の財務・戦略的SWOT分析
    Teradata Corp (TDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Arca Continental SAB de CV:戦略・SWOT・企業財務分析
    Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Axel Springer SE:企業のM&A・事業提携・投資動向
    Axel Springer SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Axel Springer SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Macquarie Group Ltd:企業の戦略・SWOT・財務分析
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MDF Instruments Direct, Inc.:企業の戦略的SWOT分析
    MDF Instruments Direct, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Daikin Industries, Ltd.:企業の戦略・SWOT・財務分析
    Daikin Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daikin Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Conn’S, Inc.:企業の戦略・SWOT・財務分析
    Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report Summary Conn'S, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆